Customized Oral and Maxillofacial Reconstruction

Sponsor
KU Leuven (Other)
Overall Status
Suspended
CT.gov ID
NCT04884126
Collaborator
(none)
150
308

Study Details

Study Description

Brief Summary

Regional oral and maxillofacial defects secondary to ablative tissue resection can contribute to severe aesthetic and functional loss, which influences patients' regular life and may cause psychological problems. Microvascular free flaps are considered the gold standard for reconstructing large oral and maxillofacial defects. In the past decade, with the help of computer-aided design (CAD)/ computer-aided manufacturing (CAM) customized implants and prosthesis (CIP) have led to a significant improvement of the operative accuracy, improve the flap survival rate and enhance the patients' quality of life.

Concerning the increased overall survival rate of the patients, people pay more attention to the quality of life and aesthetic appearance which are influenced by the fitness and compatibility of the CIP. However, from literature reviews, the evaluation was various to be concluded in some certain conditions from pooled studies.

Condition or Disease Intervention/Treatment Phase
  • Procedure: dental implant placement

Detailed Description

The trial will be conducted in compliance with the principles of the Declaration of Helsinki (specifying which amendment), the principles of GCP, and all of the applicable regulatory requirements. This protocol and related documents will the for review to the Ethics Committee. The Investigator and the Participating Site shall treat all information and data relating to the Study disclosed to Participating Site and/or Investigator in this Study as confidential and shall not disclose such information to any third parties or use such information for any purpose other than the performance of the Study. The collection, processing, and disclosure of personal data, such as patient health and medical information is subject to compliance with applicable personal data protection and the processing of personal data (Directive 95/46/EC and Belgian law of December 8, 1992, on the Protection of the Privacy in relation to the Processing of Personal Data). The extracted data will be encoded, the subject's EAD-number will be stored separately(site file) from the research data and replaced with a unique study ID-code to create a new identity for the subject. The file containing the patient-specific EAD-numbers will be kept on a secured UZ Leuven servers.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Accuracy, Fitness, Compatibility, and Clinical Outcomes of Customized Implants and Prosthesis in Oral and Maxillofacial Reconstruction
Actual Study Start Date :
Jan 1, 1996
Actual Primary Completion Date :
May 1, 2021
Anticipated Study Completion Date :
Sep 1, 2021

Arms and Interventions

Arm Intervention/Treatment
One stage dental implants placement

Procedure: dental implant placement
The time of dental implant surgery

Second stage dental implants placement

Procedure: dental implant placement
The time of dental implant surgery

Outcome Measures

Primary Outcome Measures

  1. The survival rate of the dental implants [12 months after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    1. Patients with grafted bone (fibula, iliac, scapula) and receive postoperative implant surgery.

2.Clinical and radiogram data were available for all treatment periods and follow-up visits (Pre-/post-CBCT and panoramic radiographs).

3.Over twelve months follow-up period after implant placement. 4.Age > 18 years. 5.Fabrication and delivery of prosthesis following implant installation. 6.Treatment with a one-stage/two-stage surgical protocol.

Exclusion Criteria:
  1. Patients diagnosed with osteoporosis.

  2. Lost or missing medical history during follow-up period.

  3. Follow-up period of dental implants was less than 12 months.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • KU Leuven

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hongyang Ma, PhD researcher,, KU Leuven
ClinicalTrials.gov Identifier:
NCT04884126
Other Study ID Numbers:
  • S63615
First Posted:
May 12, 2021
Last Update Posted:
May 12, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hongyang Ma, PhD researcher,, KU Leuven
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 12, 2021